Parker Institute, Tessa in cell therapy deal

In a new multi-year deal, the Parker Institute for Cancer Immunotherapy (San Francisco, Calif.) and Tessa Therapeutics Pte. Ltd. (Singapore)

Read the full 206 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE